VIVE OTC
Viveve Medical, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +100.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$6M
+17.3% ▲
5Y CAGR: -2.1%
Gross Profit
$620K
+109.5% ▲
5Y CAGR: -24.5%
Operating Income
-$22M
-16.5% ▼
Net Income
-$22M
-0.5% ▼
EPS (Diluted)
$-2.65
+84.0% ▲
EBITDA
-$20M
-1.6% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $15M | $19M | $7M | $5M | $6M |
| YoY Growth | +114.1% | +21.1% | -64.5% | -16.6% | +17.3% |
| Cost of Revenue | $8M | $11M | $6M | $5M | $6M |
| Gross Profit | $7M | $7M | $1M | $296K | $620K |
| Gross Margin | 48.7% | 39.5% | 15.5% | 5.4% | 9.6% |
| R&D Expenses | $12M | $14M | $9M | $5M | $10M |
| SG&A Expenses | $29M | $39M | $22M | $14M | $13M |
| Operating Expenses | $41M | $52M | $31M | $19M | $22M |
| Operating Income | -$34M | -$45M | -$30M | -$18M | -$22M |
| Operating Margin | -220.6% | -242.8% | -455.9% | -337.6% | -335.4% |
| Interest Expense | $3M | $4M | $4M | $910K | $1M |
| Income Before Tax | -$37M | -$49M | -$42M | -$22M | -$22M |
| Tax Expense | -$329K | -$142K | $5M | $383K | $256K |
| Net Income | -$37M | -$49M | -$43M | -$22M | -$22M |
| Net Margin | -239.6% | -265.6% | -647.6% | -400.0% | -342.8% |
| EPS (Diluted) | $-2093.62 | $-1583.50 | $-121.91 | $-16.56 | $-2.65 |
| EBITDA | -$33M | -$44M | -$31M | -$19M | -$20M |
| Shares Outstanding | 17496 | 31059 | 383233 | 2M | 10M |